Trials / Completed
CompletedNCT04268953
Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production
A Phase 1, Single-centre, Multiple-dose, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of the AC-SD-03 Formulation of Tricaprilin in Healthy Older Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Cerecin · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase I, single center, open label, multiple dose, pharmacokinetic (PK) study recruiting healthy older subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tricaprilin | Tricaprilin formulated as AC-SD-03 mixed in 300mL water |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2020-03-26
- Completion
- 2020-05-01
- First posted
- 2020-02-13
- Last updated
- 2020-07-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04268953. Inclusion in this directory is not an endorsement.